Please assess the completion status of the following clinical trial:

Trial Title: Telavancin Observational Use Registry (TOUR)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~-received at least 1 dose of telavancin since January 1, 2015~Exclusion Criteria:~* Participation in an interventional research study or clinical trial involving telavancin after January 01, 2015

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vibativ (Type: None): This is an observational study for patients who were already prescribed Vibativ.

Based on this trial design, predict the completion outcome and termination type (if applicable).